Plumbagin targets the GLUT1/MMP-2 axis to inhibit oral squamous cell carcinoma progression
Abstract Aim This study aimed to investigate the clinicopathological characteristics and prognostic value of GLUT1 in oral squamous cell carcinoma (OSCC) and the effect of plumbagin (PLB) on inhibiting OSCC invasion and metastasis through the GLUT1/Matrix Metalloproteinase 2 (MMP2) axis pathway. Mat...
Saved in:
| Main Authors: | Fei He, Weiqi Wang, Sadam Ahmed Elayah, Linyang Xie, Ming Yu, Yuxin Gong, Hao Cui, Xiang Liang, Junbo Tu, Ying Han, Sijia Na |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03915-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the power of plumbagin: revitalizing exhausted T cells to combat tongue cancer
by: Rongrong Zhang, et al.
Published: (2025-07-01) -
Potent anti-biofilm properties of plumbagin against fluconazole-resistant Candida auris
by: Hye-Won Jin, et al.
Published: (2025-03-01) -
Antibacterial activity and potential mechanisms of plumbagin against Escherichia coli and its application in milk
by: Long Guo, et al.
Published: (2025-01-01) -
The Occurrence, Uses, Biosynthetic Pathway, and Biotechnological Production of Plumbagin, a Potent Antitumor Naphthoquinone
by: Polavarapu B. Kavi Kishor, et al.
Published: (2025-04-01) -
Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)